FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart

Martin Ford, Edward Smith, Laurie Tomlinson, Prabal Chatterjee, Chakravarthi Rajkumar, Stephen Holt

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart'. Together they form a unique fingerprint.

Medicine & Life Sciences